Read the latest news about HTG’s CDx plans and other alliances!
Following End of Qiagen Deal, HTG Molecular to Focus on CDx Plans and Other Alliances
- Category:
- News
News & Events
HTG to speak at the Liquid Biopsy Summit
HTG presentation on the Methods and Challenges of Quantitative miRNA Profiling
- Category:
- Past Events
HTG EdgeSeq Mouse mRNA Tumor Response Panel Used by Researchers Targeting Cardiac Fibrosis with Engineered T-cells
TUCSON, Ariz. , Feb. 11, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the HTG EdgeSeq Mouse mRNA Tumor Response Panel as a way to identify endogenous targets of cardiac…
- Category:
- Press Releases
HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker
TUCSON, Ariz. , Feb. 05, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the reproducibility of the HTG EdgeSeq miRNA Whole Transcriptome Assay (miRNA WTA), as reported in a…
- Category:
- Press Releases
15th Annual Biomarkers Congress Genomic Markers Congress
Join HTG at the 15th Annual Biomarkers Congress along with our guest speaker, Dr. Megan Lloyd, University of Southampton Academic Unit of Cancer Sciences
- Category:
- Past Events
HTG EdgeSeq System User Manual RUO Digital Edition
The digital edition of the HTG EdgeSeq System User Manual (RUO) is a new tool designed to stream-line and enhance your customer experience.
- Category:
- News
HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma
TUCSON, Ariz. , Jan. 28, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received notification of validation of European patent number EP 3356554 for its methods for…
- Category:
- Press Releases
HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results
Preliminary full year 2019 unaudited revenue of $19.2 million Cash and cash equivalents of $33.0 million as of December 31, 2019 TUCSON, Ariz. , Jan. 13, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision…
- Category:
- Press Releases
HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine
TUCSON, Ariz. , Dec. 03, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it will host a Key Opinion Leader (KOL) luncheon at 12:00 pm ET on Friday, December 13 th in Boston,…
- Category:
- Press Releases
BMS R&D Symposium
Meet us in Long Branch, NJ for the 2019 BMS R&D Symposium!
- Category:
- Past Events
HTG Molecular Diagnostics Expands Analytics Capabilities with Release of New Software Update
HTG EdgeSeq Reveal software version 2.0.0 streamlines data analysis process and enhances user experience TUCSON, Ariz. , Nov. 19, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, yesterday…
- Category:
- Press Releases
HTG Molecular Diagnostics Reports Third Quarter 2019 Results
Product and product-related services revenue increased by 228% and 125% in the three and nine-month periods, respectively, compared to the prior year periods Call scheduled for today, November 12 , at 4:30pm ET TUCSON, Ariz. , Nov. 12, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
- Category:
- Press Releases
Page last updated March 20, 2023